The emerging roles of artificial intelligence in cancer drug development and precision therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
PMID: 32446113

Abstract

Artificial intelligence (AI) has strong logical reasoning ability and independent learning ability, which can simulate the thinking process of the human brain. AI technologies such as machine learning can profoundly optimize the existing mode of anticancer drug research. But at present AI also has its relative limitation. In this paper, the development of artificial intelligence technology such as deep learning and machine learning in anticancer drug research is reviewed. At the same time, we look forward to the future of AI.

Authors

  • Guosheng Liang
    Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang, The Marine Medical Research Institute of Guangdong Zhanjiang (GDZJMMRI), Guangdong Medical University, Zhanjiang, China.
  • Wenguo Fan
    Department of Anesthesiology, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
  • Hui Luo
    Thoracic Surgery Department, Nan Chong Center Hospital, Nanchong, China.
  • Xiao Zhu
    Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang, The Marine Medical Research Institute of Guangdong Zhanjiang (GDZJMMRI), Guangdong Medical University, Zhanjiang, China. Electronic address: xzhu@gdmu.edu.cn.

Keywords

External Resources

Popular Topics
Recent Journals